WELLINGTON, April 29, 2026, 22:03 (NZST)
- The S&P/NZX 50 eked out a 5.901-point gain to finish at 12,770.300, a rise of 0.05%. The index barely budged, trading between 12,726.35 and 12,783.97 throughout the session.
- Fisher & Paykel Healthcare added 1.48%, closing at NZ$36.25. The stock saw NZ$16.7 million change hands, supplying much of the index’s lift.
- Investors zeroed in on inflation signals from the Reserve Bank of New Zealand, U.S. megacap earnings, Fed developments, and a new round of travel-demand cautions from Booking Holdings as the session wrapped up.
Wednesday saw the New Zealand stock market inch up, as the S&P/NZX 50 managed a slight gain, barely making it into the green. Fisher & Paykel Healthcare, along with the power sector, did enough to counter declines in travel, retail, and dairy shares. It wasn’t a big move, but with a softer tone across the rest of the board and recent pressure on the local benchmark, it counted.
The index clawed back 5.901 points to finish at 12,770.300, after dropping 0.86% in the last session. According to Investing.com, 28.78 million shares changed hands on the day. The market started at 12,764.40 and slipped to 12,726.35 at its lowest.
New Zealand’s S&P/NZX 50 stands as the top share-market index, measuring the performance of the 50 biggest eligible companies by float-adjusted market value on the NZX Main Board — essentially, that’s the value of shares typically up for grabs among investors.
Defensive tones dominated the close. Shares of Fisher & Paykel Healthcare advanced 1.48% to NZ$36.25. Turnover reached 461,459 shares, pushing value traded to NZ$16.7 million. “If it wasn’t for F&P Healthcare, our market would be weaker,” said Peter McIntyre, investment adviser at Craigs Investment Partners. NZX
Power names caught some bids too. Contact Energy picked up 1% to NZ$9.32, Meridian Energy edged up 0.4% at NZ$5.55, Mercury NZ was ahead 0.6% to NZ$6.71, and Genesis Energy finished 0.4% stronger at NZ$2.39. NZX figures put health-care up 0.84% and utilities up 0.63%—just a couple of the few spots showing real support.
Fletcher Building climbed 1.1%, finishing at NZ$2.81, after Forsyth Barr kept its “outperform” call and NZ$3.80 target. The move follows Fletcher’s decision to sell its Fletcher Reinforcing and Wire business to United Industries for NZ$15.7 million. Fletcher expects a loss on the sale, putting the figure between NZ$20 million and NZ$23 million once the transaction closes. Good Returns
Things looked rougher elsewhere. KMD Brands slid 6.15% to 6.1 NZ cents, trading 3.35 million shares, according to NZX data. Serko tumbled 4.5%, Tourism Holdings slipped 2.9%. Ryman Healthcare and NZX Ltd made the list of key laggards today.
Travel stocks stumbled after Booking Holdings lowered its full-year revenue outlook, flagging that the ongoing war in the Middle East may continue to drag on bookings into late June. The company reported that first-quarter room night growth took about a 2 percentage point hit from the unrest. CFO Ewout Steenbergen also highlighted shifts in “broader travel patterns.” Reuters
Dairy stocks weighed on the session. Fonterra Shareholders’ Fund dropped 4.6% to NZ$6.40. Shares of a2 Milk slipped 1.8% to NZ$8.72. Synlait Milk tumbled 7.8% to 41.5 NZ cents, marking the steepest decline among main board names.
Rates drew attention once more as RBNZ Governor Anna Breman reported annual consumer price inflation hitting 3.1% in the March quarter—just above the central bank’s 1% to 3% target range—even as core inflation measures stayed steady within that band. On April 8, the RBNZ left its official cash rate unchanged at 2.25%. Breman said policymakers are still “ready to act decisively” if short-term price pressures start to stick. Reserve Bank of New Zealand
Regional action was mixed. The S&P/ASX 200 in Australia slipped 0.3% by late trade, while Japan’s Nikkei 225 registered a 1% drop. Hong Kong’s Hang Seng, on the other hand, advanced 1.4%. Consumer prices in Australia surged in the first quarter, with higher energy costs tied to the Middle East conflict. Stephen Smith at Deloitte Access Economics called the data a signal: “points to a rate hike” from the Reserve Bank of Australia next week. Good Returns
Still, Wednesday’s green finish may paint too rosy a picture for the NZX. Earlier in the day, losers actually outpaced winners. By the close, the bulk of the gains came down to Fisher & Paykel Healthcare plus a few defensive plays. The index could face fresh pressure if Wall Street falters, central banks get tougher on inflation, or travel snarls deepen.
